DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hytrin (Terazosin) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Hytrin (Terazosin). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (10)
     Hypotension (2)Drug Interaction (2)Fall (2)more >>

Cases resulting in a serious event (10)
     Hypotension (2)Drug Interaction (2)Fall (2)more >>

Cases resulting in hospitalization (3)
     Fall (2)Hypotension (1)Coma (1)more >>

Cases resulting in other serious reactions (8)
     Drug Interaction (2)Prostatic Specific Antigen Increased (2)Neoplasm Malignant (2)more >>

Adverse event in male receiving Hytrin (Terazosin)

Reported by a consumer/non-health professional from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Prostatic Specific Antigen Increased, Neoplasm Malignant

Suspect drug(s):
Avodart
    Dosage: .5mg per day
    Administration route: Oral
    Indication: Benign Prostatic Hyperplasia

Hytrin
    Indication: Drug USE FOR Unknown Indication



Adverse event in male receiving Hytrin (Terazosin)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: male

Adverse reactions / side effects: Prostatic Specific Antigen Increased, Neoplasm Malignant

Suspect drug(s):
Avodart
    Dosage: .5mg per day
    Administration route: Oral
    Indication: Benign Prostatic Hyperplasia

Hytrin
    Indication: Drug USE FOR Unknown Indication



Adverse event in female receiving Hytrin (Terazosin)

Reported by a consumer/non-health professional from Australia on 2007-07-17

Patient: female

Adverse reactions / side effects: Drug Interaction, Neutropenia

Suspect drug(s):
Epilim
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Epilim
    Dosage: dose decreased

Hytrin
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-09-26
    End date: 2006-10-06

Other drugs received by patient possibly interacting with the suspect drug:
Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 1998-06-06

Other drugs received by patient: Amisulpride



Adverse event in male receiving Hytrin (Terazosin)

Reported by a consumer/non-health professional from United States on 2007-07-03

Patient: male

Adverse reactions / side effects: Concussion, Hypotension, Dizziness, Coma, Fall

Adverse event resulted in: hospitalization

Suspect drug(s):
Hytrin (Terazosin)

Other drugs received by patient: M.v.i.



Adverse event in male receiving Hytrin (Terazosin)

Reported by a pharmacist from United Kingdom on 2007-06-13

Patient: male

Adverse reactions / side effects: Orthostatic Hypotension, Fall

Adverse event resulted in: hospitalization

Suspect drug(s):
Hytrin
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-09
    End date: 2007-01-31

Hytrin
    Administration route: Oral
    Start date: 2007-01-31

Hytrin
    Dosage: dose decreased
    Administration route: Oral

Other drugs received by patient: Amlodipine; Atorvastatin Calcium; Asasantin



Adverse event in female receiving Hytrin (Terazosin)

Reported by a health professional (non-physician/pharmacist) from Australia on 2007-06-07

Patient: female

Adverse reactions / side effects: Drug Interaction, Neutropenia

Suspect drug(s):
Epilim
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Epilim
    Dosage: dose decreased

Hytrin
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-09-26
    End date: 2006-10-06

Other drugs received by patient possibly interacting with the suspect drug:
Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 1998-06-06

Other drugs received by patient: Amisulpride



Adverse event in male receiving Hytrin (Terazosin)

Reported by a physician from United States on 2007-02-05

Patient: male, weighing 98.0 kg (215.5 pounds)

Adverse reactions / side effects: Drug Ineffective, Drug Intolerance, Anuria

Suspect drug(s):
Hytrin (Terazosin)



Adverse event in male receiving Hytrin (Terazosin)

Reported by a physician from United States on 2007-01-25

Patient: male, weighing 86.3 kg (189.8 pounds)

Adverse reactions / side effects: Sepsis, Prostatic Operation, Erectile Dysfunction

Adverse event resulted in: hospitalization

Suspect drug(s):
Hytrin (Terazosin)

Other drugs received by patient: Rozerem; Wellbutrin XL



Adverse event in 82 year old male receiving Hytrin (Terazosin)

Reported by a pharmacist from United States on 2007-01-24

Patient: 82 year old male, weighing 69.1 kg (152.0 pounds)

Adverse reactions / side effects: Hypotension

Suspect drug(s):
Hytrin (Terazosin)



Adverse event in 58 year old male receiving Hytrin (Terazosin)

Reported by a individual with unspecified qualification from United States on 2007-01-22

Patient: 58 year old male, weighing 97.5 kg (214.6 pounds)

Adverse reactions / side effects: Circadian Rhythm Sleep Disorder, Ligament Rupture, Activities of Daily Living Impaired, Palpitations, Muscle Tightness, Pharmaceutical Product Complaint

Suspect drug(s):
Hytrin
    Dosage: 1mg 1 at bedtime po
    Administration route: Oral
    Indication: Benign Prostatic Hyperplasia
    Start date: 2006-03-01
    End date: 2006-04-01

Terazosin HCL
    Dosage: 1mg 1 at bedtime po
    Administration route: Oral
    Indication: Benign Prostatic Hyperplasia
    Start date: 2006-11-21
    End date: 2007-01-18

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009